TickerFactsScreenerDevelopers

Aptose Biosciences Inc. (APTOF) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$10.22M2018: -$23.21M2019: -$21.56M2020: -$33.89M2021: -$43.30M2022: -$32.32M2023: -$44.59M2024: -$35.98M2025: -$21.99M-$21.99M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$21.99M+38.9%
2024-$35.98M+19.3%
2023-$44.59M-38.0%
2022-$32.32M+25.4%
2021-$43.30M-27.8%
2020-$33.89M-57.2%
2019-$21.56M+7.1%
2018-$23.21M-127.0%
2017-$10.22M—